Sun Pharmaceutical Industries : Loss of Share Certificates
January 23, 2022 at 06:14 am EST
Share
Sun Pharmaceutical Industries Limited
Sun House, Plot No. 201 B/1,
Western Express Highway, Goregaon (E),
Mumbai - 400 063, Maharashtra, INDIA.
Tel. : (91-22) 4324 4324
Fax : (91-22) 4324 4343
Website: www.sunpharma.com
CIN: L24230GJ1993PLC019050
January 22, 2022
National Stock Exchange of India Ltd.,
BSE Limited,
Exchange Plaza, 5th Floor,
Market Operations Dept.
Plot No. C/1, G Block,
P. J. Towers,
Bandra Kurla Complex,
Dalal Street,
Bandra (East), Mumbai - 400 051.
Mumbai - 400 001.
NSE Code: SUNPHARMA
Stock Code: 524715
Dear Sirs,
Sub: Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of issue of duplicate share certificate to the following shareholder on 21st January,2022 :
Sr. No.
Folio
Name of the
New
Share Distinctive Nos.
No. of
No.
Shareholder(s)
Share
shares
Certificate
of
No.
Re.1
each
1.
012336
Preeti Jejani
272731
027206371
1027206730
360
1036019651
036020010
360
This is for your information and record.
Thanking you,
Yours faithfully,
For Sun Pharmaceutical Industries Limited
Ashok
Indulal
Bhuta
Digitally signed by Ashok Indulal Bhuta Date: 2022.01.22 19:29:57 +05'30'
Ashok Bhuta
Sr. GM - Secretarial & Compliance Officer
Registered Office: SPARC, Tandalja, Vadodara - 390 012, Gujarat, INDIA.
Reaching People. Touching Lives.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Sun Pharmaceutical Industries Ltd. published this content on 23 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 January 2022 11:13:04 UTC.
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows:
- generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment;
- other (6%) : primarily active pharmaceutical ingredients.
At the end of March 2021, the group had 44 production plants worldwide.
Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).